The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 31, 2021
Filed:
Mar. 14, 2014
Applicant:
Holaira, Inc., Plymouth, MN (US);
Inventors:
Martin L. Mayse, Wayzata, MN (US);
Steven P. Mertens, Plymouth, MN (US);
Assignee:
Nuvaira, Inc., Plymouth, MN (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61M 25/10 (2013.01); A61M 29/02 (2006.01); A61L 31/16 (2006.01); A61K 31/167 (2006.01); A61K 31/138 (2006.01); A61K 31/045 (2006.01); A61K 31/185 (2006.01); A61K 33/00 (2006.01); A61K 31/14 (2006.01); A61K 31/436 (2006.01); A61K 31/7004 (2006.01); A61K 31/05 (2006.01); A61K 31/201 (2006.01); A61K 31/445 (2006.01); A61K 31/166 (2006.01); A61K 31/191 (2006.01); A61L 29/16 (2006.01); A61K 38/17 (2006.01); A61K 33/36 (2006.01);
U.S. Cl.
CPC ...
A61M 29/02 (2013.01); A61K 31/045 (2013.01); A61K 31/05 (2013.01); A61K 31/138 (2013.01); A61K 31/14 (2013.01); A61K 31/166 (2013.01); A61K 31/167 (2013.01); A61K 31/185 (2013.01); A61K 31/191 (2013.01); A61K 31/201 (2013.01); A61K 31/436 (2013.01); A61K 31/445 (2013.01); A61K 31/7004 (2013.01); A61K 33/00 (2013.01); A61K 33/36 (2013.01); A61K 38/1732 (2013.01); A61K 38/1735 (2013.01); A61L 29/16 (2013.01); A61L 31/16 (2013.01); A61M 25/104 (2013.01); A61L 2300/402 (2013.01); A61M 2025/105 (2013.01); A61M 2025/1086 (2013.01);
Abstract
A medication delivery device for treatment of a pulmonary disorder in a patient includes an elongate member, an expandable member is coupled to a distal end of the elongate member, and an agent delivery portion coupled to an external surface of the expandable member. The agent delivery portion includes an agent that disrupts nerve activity.